• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[On the meaning of psychometrically operationalized therapeutic effects in the treatment of brain insufficiency phenomena caused by old age demonstrated by the "Nürnberger-Alters-Inventar" (author's transl)].

作者信息

Oswald W D, Matejcek M, Lukaschek K, Dennler H J, Oswald B

出版信息

Arzneimittelforschung. 1982;32(5):584-90.

PMID:7201839
Abstract

The drug effects of dihydroergotoxine (Hydergin) and piracetam were examined in a sample of 44 old-age home residents, 76 years average age, using performance tests, nurse-ratings for the need of care and self-evaluation measures of the "Nürnberger Alters-Inventar" (NAI). Within a subsample of 18 patients, selected according to certain EEG-criteria, EEG day profiles were assessed. The medication lasted for 6 weeks. 2 mg dihydroergotoxine or 0.8 g piracetam, respectively, were applied three times a day. Initial effects were observed for both medications after 3 weeks in terms of improvements in the cognitive performance, for the activities of daily living and need of care, respectively, and for subjective, physical, functional and social self-evaluations. After 6 weeks, at the end of the study, these effects were confirmed only for dihydroergotoxine, whereas the piracetam subjects could not stabilize these improvements. The psychometric results were corroberated by the EEG-data. Correlations between the independent levels of psychometric assessment did demonstrate the meaning of the performance measures in terms of activities of daily living and subjective well-being.

摘要

相似文献

1
[On the meaning of psychometrically operationalized therapeutic effects in the treatment of brain insufficiency phenomena caused by old age demonstrated by the "Nürnberger-Alters-Inventar" (author's transl)].
Arzneimittelforschung. 1982;32(5):584-90.
2
[Piracetam and vigilance. A study of EEG changes and clinical effects in gerontopsychiatric patients (author's transl)].
Arzneimittelforschung. 1978;28(9):1529-30.
3
[Treatment of organic brain psychosyndrom in the old age. A double blind study with Hydergin (author's transl)].
Med Klin. 1976 Dec 3;71(49):2177-84.
4
[Clinical trial of the use of the combination of piracetam and dihydroergocristine in vertigo from different causes].
An Otorrinolaringol Ibero Am. 1989;16(3):271-9.
5
[Course of alcoholic predelirium during treatment with piracetam: results of serial psychometric tests (author's transl)].
Dtsch Med Wochenschr. 1979 Jun 22;104(25):911-4. doi: 10.1055/s-0028-1104013.
6
[Evaluation of the therapeutic effectiveness of a piracetam plus dihydroergocristine combination in the treatment of vertigo].
Acta Otorrinolaringol Esp. 1988 Jul-Aug;39(4):287-8.
7
[The effect of treatment on performance and self-appraisal in geriatric patients (author's transl)].
MMW Munch Med Wochenschr. 1980 Jan 11;122(2):59-62.
8
[Pilot study of 2-pyrrolidon-acetamid (generic name: piracetam) (author's transl)].
Pharmakopsychiatr Neuropsychopharmakol. 1975 Mar;8(2):82-9. doi: 10.1055/s-0028-1094446.
9
[Eutergin in the treatment of chronic cerebrovascular disturbance patterns (author's transl)].
Aktuelle Gerontol. 1980 Jun;10(6):245-51.
10
[The effect of pharmacological treatment in the compensation of vertigo].[药物治疗在眩晕代偿中的作用]
An Otorrinolaringol Ibero Am. 1999;26(3):271-91.

引用本文的文献

1
Hydergine for dementia.喜得镇治疗痴呆症。
Cochrane Database Syst Rev. 2000;2000(2):CD000359. doi: 10.1002/14651858.CD000359.
2
Co-dergocrine mesylate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in age-related cognitive decline.甲磺酸双氢麦角隐亭。其药效学、药代动力学特性及在年龄相关性认知功能减退中的治疗应用综述
Drugs Aging. 1992 May-Jun;2(3):153-73. doi: 10.2165/00002512-199202030-00002.